News - Savient Pharmaceuticals


Current filters:

Savient Pharmaceuticals

Popular Filters

Savient files for voluntary bankruptcy protection; plans asset sale


US drugmaker Savient Pharmaceuticals says it has elected to file voluntary petitions under Chapter 11…

FinancialKrystexxaMergers & AcquisitionsPharmaceuticalSavient Pharmaceuticals

SOBI links with Savient for co-promotion of Kineret in USA


Swedish Orphan Biovitrum (STO: SOBI) says it has entered into an agreement with USA-based Savient Pharmaceuticals…

Anti-Arthritics/RheumaticsInflammatory diseasesKineretLicensingMarkets & MarketingNorth AmericaPharmaceuticalSavient PharmaceuticalsSobiSwedish Orphan Biovitrum

Savient's Krystexxa gets final EU approval for chronic tophaceous gout


US drugmaker Savient Pharmaceuticals (Nasdaq: SVNT) says that the European Commission has granted a marketing…

EuropeInflammatory diseasesKrystexxaPharmaceuticalRegulationSavient Pharmaceuticals

Chelsea Therapeutics and Savient to slash jobs


Chelsea Therapeutics International (Nasdaq: CHTP) yesterday announced restructuring plans to "significantly…

BiotechnologyChelsea TherapeuticsFinancialKrystexxaManagementNortheraSavient Pharmaceuticals

Allopurinol remains gout market leader but Uloric making inroads, study finds


Most surveyed rheumatologists, nephrologists and primary care physicians cite increased use of Takeda's…

allopurinolAnti-Arthritics/RheumaticsGenito-urinaryKrystexxaMarkets & MarketingPharmaceuticalSavient PharmaceuticalsTakeda PharmaceuticalsUloric

Several abstracts on gout reveal true burden of disease and highlight promising new treatments


New studies on gout were presented this week at EULAR, the Annual Congress of the European League Against…

allopurinolAnti-Arthritics/RheumaticsKrystexxalesinuradPharmaceuticalRegulationResearchSavient Pharmaceuticals

EC approves Pfizer’s Revatio for PAH in children; Savient files Krystexxa with EMA


US drugs behemoth Pfizer (NYSE: PFE) yesterday revealed that Revatio (sildenafil citrate, which is also…

Anti-Arthritics/RheumaticsCardio-vascularEuropeKrystexxaPfizerPharmaceuticalRegulationRespiratory and PulmonaryRevatioSavient Pharmaceuticals

Back to top